Wall Street Analyst Sees SpaceX Upside, I’m Skeptical
A prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesA prominent analyst argues SpaceX could surge, but practical hurdles and private-market realities temper the enthusia...
A legendary investor bets on a familiar retailer. This guide shows how to spot similar bargains, evaluate their upsid...
Jim Cramer highlights Dollar General as a hedge fund favorite as energy costs rise, sending shoppers toward discount ...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
February brought an 11% slide in main street capital stock as investors weighed private credit risk and rising rates....
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
Chase has cut credit-card limits for some customers with minimal usage, raising questions about credit-score impact a...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
A surprising move in the stock market drew attention to Super Micro Computer. This article breaks down the forces beh...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
Poet Technologies stock sold off again as investors weigh dilution, growth prospects, and market jitters. This analys...